Blood Flow Measurement Using Quantitative Magnetic Resonance Angiography and Duplex Sonography
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03591523|
Recruitment Status : Recruiting
First Posted : July 19, 2018
Last Update Posted : August 8, 2018
|Condition or disease||Intervention/treatment|
|Cerebrovascular Circulation||Diagnostic Test: Quantitative MR angiography Diagnostic Test: Duplex sonography|
Introduction: Measurement of blood flow in cervical and cerebral arteries is important not only for accurate diagnosis of neurovascular diseases but also for refinement of the indication of invasive treatment. Quantitative MR angiography (qMRA) with NOVA flow analysis system and duplex sonography (DS; duplex sonography of cervical arteries and transcranial color-coded duplex sonography) are non-invasive diagnostics methods which could be used for measurement of blood flow in cervical and intracranial arteries.
Aim: The aim of the study is to assess the correlation of blood flow measurement in cervical and intracranial arteries between qMRA and DS in common clinical practice. The secondary aims are to assess the inter-investigator and intra-investigator correlations of both qMRA and DS in blood flow measurement.
Methods: A total of 21 subjects indicated to qMRA or DS for suspicion of cervical or intracranial vascular pathology will be included.
Inclusion criteria: male or female; age 25 - 70 years; signed informed consent. Exclusion criteria: contraindication to magnetic resonance; uncontrolled involuntary movements; other condition preventing long-term quiet lying.
All patients will undergo qMRA and DS of the cervical and intracranial arteries within 2 hours. The NOVA flow analysis system will calculate blood flow in individual segments. In DS, angle corrected blood flow velocities (peak systolic velocity - PSV, end-diastolic velocity - EDV, mean velocity - Vmean) will be measured in individual segments with measurement of arterial in the B-Mode or Color Mode with automatic calculation of blood flow.
The blood flow will be assessed in the following arterial segments: bilateral common carotid artery (CCA), internal carotid artery in proximal part distally to carotid bulb (ICA) and in distal carotid siphon (ICA-siphon), external carotid artery (ECA), vertebral artery in V2 (V2-VA) and V4 (V4-VA) segments, middle cerebral artery (MCA), anterior cerebral artery in pre-communicant (ACA1) and post-communicant (ACA2) part, posterior cerebral artery in pre-communicant (PCA1) and post-communicant (PCA2) part and basilar artery (BA) the cerebral artery.
At least 2 patients will undergo qMRA and DS performed by the same investigators twice in the time interval of 2 - 10 days and DS will be performed in all patients by 2 sonographers using 2 different machines for assessment of inter-investigator and intra-investigator reliability.
All investigators will be blinded to the diagnosis and measurement performed using other diagnostics method.
In all patients will be collecting following data: blood pressure, weight, height, age, gender, time of examination Statistics: Correlations between measurements will be evaluated using Spearman's correlation coefficient or kappa coefficient and inter-class correlation coefficient (ICC).
|Study Type :||Observational|
|Estimated Enrollment :||21 participants|
|Official Title:||Blood Flow Measurement in Cervical and Cerebral Arteries Using Quantitative Magnetic Resonance Angiography and Cervical and Transcranial Duplex Sonography|
|Actual Study Start Date :||August 6, 2018|
|Estimated Primary Completion Date :||August 31, 2018|
|Estimated Study Completion Date :||August 31, 2018|
Suspicion of vascular pathology
Subjects indicated to quantitative MR angiography and duplex sonography for suspicion of cervical or intracranial vascular pathology
Diagnostic Test: Quantitative MR angiography
Quantitative MR angiography: A standard axial 3-dimensional time-of-flight (TOF) MRA of intracranial and cervical arteries will be obtained. Then, the acquired images will be transmitted to the workstation to reconstruct 3D surface-rendered vessel images. After determining optimal perpendicular scan plane and setting the baseline coordinates , retrospectively gated, fast 2-dimensional phase-contrast sequence will be performed. Velocity encoding will be automatically adjusted by NOVA software.
Other Name: qMRA
Diagnostic Test: Duplex sonography
Duplex sonography of cervical arteries will be performed using 5 - 12 MHz linear duplex probe and transcranial color-coded duplex sonography will be performed using 2 - 5 MHz transcranial duplex probe. Peak systolic velocity, end diastolic celocity, mean blood flow velocity and arterial diameter will be measured with automatic calculation of blood flow velocity in each arterial segment.
Other Name: DS
- Blood flow measurement [ Time Frame: 6 weeks ]Correlation of blood flow measurement between qMRA and DS
- Intra-investigator reliability of quantitative magnetic resonance angiography [ Time Frame: 6 weeks ]Intrainvestigator reliability of blood flow measurement using qMRA performed by the same investigators in two sessions
- Inter-investigator reliability of duplex sonography [ Time Frame: 6 weeks ]Inter-investigator reliability of blood flow measurement using duplex sonography performed by 2 investigators
- Intra-investigator reliability of duplex sonography [ Time Frame: 6 weeks ]Intra-investigator reliability of blood flow measurement using duplex sonography performed by the same investigator in two sessions
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03591523
|Contact: David Skoloudik, Prof. Dr.||+firstname.lastname@example.org|
|Nemocnice Ceske Budejovice||Recruiting|
|České Budějovice, Czechia|
|Contact: Jiří Fiedler, M.D., Ph.D. 00420607868729 email@example.com|
|Contact: Martin Reiser, M.D. firstname.lastname@example.org|
|Principal Investigator:||David Skoloudik, Prof. Dr.||Palacký University Olomouc, Center for Science and Research|